Age, years | 62.0 ± 13.2 |
Sex, male, n | 22 |
Fasting/postprandial1, n | 5/26 |
Body weight, kg | 74.7 ± 14.1 |
BMI kg/m2 | 28.00 ± 4.45 |
Duration of DM, years | 12.3 ± 6.83 |
Alcohol (above 140 g/week), n | 8 |
Fibrate, n | 2 |
Statin, n | 14 |
Ezetimibe, n | 7 |
EPA/DHA2, n | 1 |
Insulin, n | 8 |
GLP-1RA, n | 6 |
DPP4I, n | 13 |
SGLT2I, n | 14 |
BG, n | 12 |
SU, n | 5 |
αGI, n | 4 |
TZD, n | 1 |
Glinide, n | 6 |
Before | At the end | p-value | Mean of differences | 95% CI | |
---|---|---|---|---|---|
TG (mg/dl) | 296.9 ± 126.0 | 205.7 ± 84.7 | 0.001> | 90.6 | 47.2 to 134.1 |
RLP-C | 10.6 ± 5.28 | 6.53 ± 3.17 | 0.0001> | 4.06 | 2.39 to 5.73 |
HDL-C | 46.4 ± 10.0 | 51.6 ± 10.3 | 0.001 | −5.19 | −8.12 to 2.27 |
Non-HDL-C | 148.5 ± 26.3 | 140.2 ± 32.7 | 0.054 | 8.23 | −0.14 to 16.6 |
LDL-C | 103.0 ± 26.3 | 106.1 ± 28.7 | 0.52 | −3.1 | −12.8 to 6.62 |
Before | At the end | p-value | Mean of differences | 95% CI | |
---|---|---|---|---|---|
Apo A1 | 130.8 ± 18.8 | 139.1 ± 18.7 | 0.0000303 | −8.23 | −11.6 to 4.80 |
Apo A2 | 32.3 ± 5.8 | 38.8 ± 6.80 | 0.00001> | −6.53 | −8.96 to 4.09 |
Apo B | 89.9 ± 13.6 | 87.9 ± 16.8 | 0.40 | 2.03 | −2.72 to 6.79 |
Apo C2 | 8.62 ± 2.03 | 7.81 ± 2.21 | 0.02 | 0.81 | 0.13 to 1.48 |
Apo C3 | 18.3 ± 6.20 | 15.5 ± 5.25 | 0.004 | 2.78 | 0.97 to 4.59 |
Apo E | 3.55 ± 1.33 | 3.01 ± 1.04 | 0.007 | 0.54 | 0.16 to 0.91 |
Before | At the end | p-value | Mean of differences | 95% CI | |
---|---|---|---|---|---|
AST | 28.4 ± 14.1 | 26.7 ± 10.6 | 0.171 | 1.61 | −0.73 to 3.96 |
ALT | 35.1 ± 27.0 | 29.1 ± 18.2 | 0.0261 | 6.06 | 0.77 to 11.35 |
γ-GT | 70.4 ± 77.0 | 51.9 ± 55.3 | 0.00424 | 18.5 | 6.30 to 30.74 |
CK | 118.2 ± 70.2 | 117.7 ± 67.9 | 0.962 | 0.48 | −20.2 to 21.2 |
Cr | 0.85 ± 0.17 | 0.86 ± 0.18 | 0.95 | −0.001 | −0.04 to 0.03 |
eGFR | 67.2 ± 14.0 | 67.2 ± 13.4 | 0.874 | 0.185 | −2.20 to 2.57 |
HbA1c | 7.46 ± 1.03 | 7.68 ± 0.98 | 0.002 | −0.22 | −0.36 to 0.09 |
PG | 172.1 ± 57.9 | 170.2 ± 48.8 | 0.819 | 1.9 | −15.0 to 18.8 |